In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-11 of 11 for your search:
Drug:  I 131 monoclonal antibody CC49
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2153, NCI-B93-0013, B93-0013
2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-93076A1, NCI-T94-0042C, T94-0042
3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-91022, NCI-T91-0216C, T91-0216
4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2112, NCI-T91-0218C, T91-0218
5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2131, NCI-T92-0169C, T92-0169
6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: UAC-2152, NCI-B93-0012, B93-0012
7.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to physiologic 65
Sponsor: NCI
Protocol IDs: UAB-9505, NCI-B95-0005, B95-0005
8.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 19 to 65
Sponsor: NCI
Protocol IDs: UNMC-28191, NCI-T91-0159O, T91-0159
9.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-93029, NCI-B92-0002, B92-0002
10.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 60
Sponsor: NCI
Protocol IDs: UAC-1151, NCI-B93-0011, B93-0011
11.

Phase: Phase I
Type: Diagnostic
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: MSKCC-90122A, NCI-T90-0207, T90-0207
New Search